The Second Annual Houston Shock Symposium 2019

The Houston Shock Symposium is a dedicated cardiogenic shock symposium that encompasses interventionalists, advanced heart failure cardiologists, cardiothoracic surgeons, cardiac physiologists, cardiologists, critical care physicians, and engineers. It is our aim to have world renowned experts in this field to share and advance knowledge, expertise, and vision to save lives and reduce shock’s unacceptable high mortality rate.

Recent Cardiology Headlines

Nutritional Supplements a Bust for CV Protection; ODYSSEY OUTCOMES

Cardio Round-up: Nutritional Supplements a Bust for CV Protections?; ODYSSEY OUTCOMES Follow-up

This week's edition has some news for those who take nutritional supplements to prevent cardiovascular outcomes, a vote of confidence for adding a PCSK9...
Alirocumab Plus Statin Reduces Death after ACS: Analysis

Alirocumab Plus Statin Reduces Death after ACS: Analysis

A recent analysis of the results of the ODYSSEY OUTCOMES trail suggests that the PCSK9 inhibitor alirocumab added to statin therapy in patients with...
Nutritional Supplements Offer No Additional Cardiovascular Protections: Analysis

Nutritional Supplements Offer No Additional Cardiovascular Protections: Analysis

A new analysis indicates that most nutritional supplements do not provide any additional protections against cardiovascular disease or cardiovascular death. The study, published in the...
Cardiac Arrest Numbers Among Hospitalized Patients Are Higher than Previously Estimated

Cardiac Arrest Numbers Among Hospitalized Patients Are Higher than Previously Estimated

In the US, hospital patients suffer cardiac arrests at a higher rate than previously thought, according to the findings of the American Heart Association journal Circulation
click me